CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune...

Area of Science:

• Immunology
• Cellular Biology
• Clinical Diagnostics

Background:

• CD69 serves as a key marker for T-lymphocyte activation in response to mitogens and antigens.
• Quantitative flow cytometry offers advantages over traditional lymphocyte proliferation assays for measuring T-cell responsiveness.
• Standardization of flow cytometry for CD69 expression is crucial for clinical applications.

Purpose of the Study:

• To qualify a commercially available assay for measuring T-cell activation via CD69 expression.
• To evaluate the assay's utility in assessing T-cell responses in immunocompromised patients.

Main Methods:

• Utilized a commercial assay kit for quantitative measurement of CD69 surface expression on T-lymphocytes.
• Stimulated peripheral blood from healthy volunteers and immunocompromised patients with phytohemagglutinin (PHA) and Staphylococcus endotoxin B (SEB).
• Employed flow cytometry to determine CD69 antibody bound per cell (ABC) levels.

Main Results:

• Healthy volunteers exhibited significant increases in CD69 expression upon PHA and SEB stimulation.
• Patients post-bone marrow transplant showed generally reduced T-cell CD69 responses compared to healthy controls.
• CD8(+) T-cell responses to SEB were notably depressed in patients, while CD4(+) T-cell responses remained comparable to controls.

Conclusions:

• Quantitative CD69 expression analysis by flow cytometry is a promising diagnostic method for evaluating T-lymphocyte activation.
• The assay effectively differentiates T-cell responses in immunocompromised individuals, particularly post-transplant.
• This technique aids in the detailed assessment of T-lymphocyte and subset function in clinical settings.